453 related articles for article (PubMed ID: 18166409)
1. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population.
Obana A; Hiramitsu T; Gohto Y; Ohira A; Mizuno S; Hirano T; Bernstein PS; Fujii H; Iseki K; Tanito M; Hotta Y
Ophthalmology; 2008 Jan; 115(1):147-57. PubMed ID: 18166409
[TBL] [Abstract][Full Text] [Related]
2. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
Bernstein PS; Zhao DY; Wintch SW; Ermakov IV; McClane RW; Gellermann W
Ophthalmology; 2002 Oct; 109(10):1780-7. PubMed ID: 12359594
[TBL] [Abstract][Full Text] [Related]
3. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population.
Beatty S; Murray IJ; Henson DB; Carden D; Koh H; Boulton ME
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):439-46. PubMed ID: 11157880
[TBL] [Abstract][Full Text] [Related]
4. Resonance Raman measurement of macular carotenoids in the living human eye.
Bernstein PS; Zhao DY; Sharifzadeh M; Ermakov IV; Gellermann W
Arch Biochem Biophys; 2004 Oct; 430(2):163-9. PubMed ID: 15369814
[TBL] [Abstract][Full Text] [Related]
5. [Macular pigment and age-related macular degeneration. Clinical implications].
Haddad WM; Souied E; Coscas G; Soubrane G
Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
7. Serum antioxidants and age-related macular degeneration among older Japanese.
Michikawa T; Ishida S; Nishiwaki Y; Kikuchi Y; Tsuboi T; Hosoda K; Ishigami A; Iwasawa S; Nakano M; Takebayashi T
Asia Pac J Clin Nutr; 2009; 18(1):1-7. PubMed ID: 19329388
[TBL] [Abstract][Full Text] [Related]
8. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
[TBL] [Abstract][Full Text] [Related]
9. Macular pigment and healthy vision.
Optometry; 2009 Oct; 80(10):592-8. PubMed ID: 20576249
[TBL] [Abstract][Full Text] [Related]
10. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
[TBL] [Abstract][Full Text] [Related]
11. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
12. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
[TBL] [Abstract][Full Text] [Related]
13. Raman detection of macular carotenoid pigments in intact human retina.
Bernstein PS; Yoshida MD; Katz NB; McClane RW; Gellermann W
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2003-11. PubMed ID: 9761278
[TBL] [Abstract][Full Text] [Related]
14. Resonance Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies.
Zhao DY; Wintch SW; Ermakov IV; Gellermann W; Bernstein PS
Arch Ophthalmol; 2003 Jul; 121(7):967-72. PubMed ID: 12860799
[TBL] [Abstract][Full Text] [Related]
15. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
[TBL] [Abstract][Full Text] [Related]
16. Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance.
Kaya S; Weigert G; Pemp B; Sacu S; Werkmeister RM; Dragostinoff N; Garhöfer G; Schmidt-Erfurth U; Schmetterer L
Acta Ophthalmol; 2012 Aug; 90(5):e399-403. PubMed ID: 23035764
[TBL] [Abstract][Full Text] [Related]
17. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.
Parisi V; Tedeschi M; Gallinaro G; Varano M; Saviano S; Piermarocchi S;
Ophthalmology; 2008 Feb; 115(2):324-333.e2. PubMed ID: 17716735
[TBL] [Abstract][Full Text] [Related]
18. Macular pigment in donor eyes with and without AMD: a case-control study.
Bone RA; Landrum JT; Mayne ST; Gomez CM; Tibor SE; Twaroska EE
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):235-40. PubMed ID: 11133874
[TBL] [Abstract][Full Text] [Related]
19. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration.
Stringham JM; Hammond BR; Nolan JM; Wooten BR; Mammen A; Smollon W; Snodderly DM
Exp Eye Res; 2008 Nov; 87(5):445-53. PubMed ID: 18778703
[TBL] [Abstract][Full Text] [Related]
20. Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration.
Parisi V; Perillo L; Tedeschi M; Scassa C; Gallinaro G; Capaldo N; Varano M
Retina; 2007 Sep; 27(7):879-90. PubMed ID: 17891012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
